摘要
本文就近10年来活血化瘀法对胃癌前病变(PLGC)的临床治疗现状,从活血化瘀法治则的建立及立法的基础、活血化瘀法对胃黏膜萎缩的疗效作用、对肠上皮化生及不典型增生的抑制作用甚或阻断和逆转作用等四个方面进行了综述。研究现状表明,活血化瘀法治疗PLGC具有理论基础和实践依据,其治法的确立符合PLGC瘀血阻滞的主要病机,活血化瘀法为治疗PLGC之常法,能显著改善PLGC临床症状,并能有效抑制PLGC进程和发展,具有临床推广应用价值。但尚需进一步凝练方药,进行规范的疗效评价研究。
This article is about the clinical treatment of gastric precancerous lesions(PLGC)in the past 10 years,from the establishment of the rule of law for promoting blood circulation and removing blood stasis,the basis of legislation,the effect of promoting blood circulation to remove blood stasis on gastric mucosal atrophy, and the intestinal epithelium.The inhibition of metaplasia and dysplasia or even the blocking and reversal effects are reviewed.The research status shows that the method of activating blood circulation and removing blood stasis has a theoretical basis and practical basis.The establishment of its treatment is in line with the main pathogenesis of PLGC blood stasis.The method of activating blood circulation to remove blood stasis is a common method for treating PLGC,which can significantly improve the clinical symptoms of PLGC.And can effectively inhibit the process and development of PLGC,with clinical application value.However,it is necessary to further consolidate the prescription and conduct a standardized evaluation of the efficacy.
作者
王熠慧
陈婉珍
朱方石
WANG Yihui;CHEN Wanzhen;ZHU Fangshi(The Third Clinical Medical School of Nanjing University of Chinese Medicine,Nanjing 210028,China)
出处
《中国医学创新》
CAS
2019年第13期169-172,共4页
Medical Innovation of China
关键词
活血化瘀法
胃癌前病变
临床研究进展
Promoting blood circulation for removing blood stasis
PLGC
Clinical research progress